CANCER AND LEUKEMIA GROUP B CCOP RESEARCH BASE

癌症和白血病B组CCOP研究基地

• 批准号: 6617897
• 负责人: RICHARD L SCHILSKY
• 金额: $ 120.64万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 1983
• 资助国家: 美国
• 起止时间: 1983-09-30 至 2004-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6617897
• 关键词: behavioral /social science research tag; biomarker; cancer prevention; cancer rehabilitation /care; chemoprevention; clinical research; clinical trials; community health services; continuing education; cooperative study; health care cost /financing; health services research tag; human subject; human therapy evaluation; leukemia; medical outreach /case finding; medical rehabilitation related tag; minimal residual disease; neoplasm /cancer chemotherapy; neoplasm /cancer diagnosis; neoplasm /cancer education; neoplasm /cancer surgery; neoplasm /cancer therapy; prognosis; quality of life

This application is submitted by the Cancer And Leukemia Group B (CALGB) to begin its sixteenth year as a primary multi-modality Research Base for seven Community Clinical Oncology Programs (CCOPs) and two Minority-Based CCOPs. CALGB is a Clinical Cooperative Group with 30 Main Member institutions and a membership of about 3000 health professionals at about 200 hospitals, clinics and physicians' offices. The overall objective is to provide an organized and collegial environment for community based health care professionals to interact with their academic counter-parts in the development and implementation of cancer prevention and control research studies and the latest cancer treatment clinical trials. CALGB proposes to enhance the translation of new information from a strong basic correlative sciences program in cancer treatment to an evolving strong program in cancer prevention and control research. Major themes are chemoprevention, intermediate markers and quality of life research. Strategies will be developed to assist CCOPs to increase accrual of minorities, women and other underserved people into ethical, high quality clinical trials which will result in a decrease in cancer incidence, morbidity and mortality. A special focus has emerged in cancer in the elderly and a new committee is charged with developing research studies of particular relevance to this rapidly growing segment of the population. CCOPs will be assisted in broadening their networks to include more primary health professionals and specialists to help in the diffusion of state-of-the-art cancer care at the community level. There are seven cancer site committees (Breast, Gastrointestinal, Leukemia, Lymphoma, Melanoma, Prostate and Respiratory) which work closely with thirteen modality committees (Pharmacology and Experimental Therapeutics, Correlative Sciences- Leukemia/Lymphoma, Correlative Sciences-Solid Tumors, Transplant, Pathology, Surgery, Radiation Oncology, Psycho-Oncology, Cancer Control, Oncology Nursing, Patient Issues, Clinical Research Associates, Cancer in the Elderly) to plan and implement cancer prevention and treatment studies using the latest technologies and information available. This project will bring these advances to the community hospital level where CCOP trained health care providers can apply them immediately.

该应用程序由癌症和白血病B组（CALGB）提交，开始了第16年，作为七个社区临床肿瘤学计划（CCOP）和两个基于少数民族的CCOP的主要多模式研究基础。 Calgb是一个临床合作组织，拥有30个主要会员机构，并在约200家医院，诊所和医生办公室拥有约3000名卫生专业人员的会员。 总体目的是为社区医疗保健专业人员提供一个有组织的大学环境，以与他们的学术反应局相互作用，以开发和实施癌症预防和控制研究研究以及最新的癌症治疗临床试验。 CALB建议增强从癌症治疗中强大的基本相关科学计划到癌症预防和控制研究中不断发展的强计划的新信息的翻译。 主要主题是化学预防，中间标记和生活质量研究。 将制定策略，以帮助CCOPS将少数族裔，妇女和其他服务不足的人的应计入伦理，高质量的临床试验增加，这将导致癌症发病率，发病率和死亡率降低。 老年人的癌症已经出现了一个特别的重点，一个新委员会负责开发与这一迅速增长的人群特别相关的研究。 CCOPS将有助于扩大其网络，以包括更多的主要卫生专业人员和专家，以帮助在社区一级扩散最先进的癌症护理。共有七个癌症现场委员会（乳房，胃肠道，白血病，淋巴瘤，黑色素瘤，前列腺和呼吸道），它们与13个模态委员会（药理学和实验性治疗学，相关科学，白血病/淋巴瘤 - 相关性科学，经验，癌症，疾病，病理，散热，散热，散热，释放，淋巴样，相关性科学，相关性科学，相关性科学，相关性科学，相关性科学 - 肿瘤学护理，患者问题，临床研究助理，老年人的癌症），使用最新技术和信息来计划和实施癌症预防和治疗研究。 该项目将把这些进步带到社区医院一级，在那里CCOP培训的医疗保健提供者可以立即应用它们。